InMode BodyTite
RF-assisted lipolysis (internal) · Bipolar RF-assisted lipolysis (RFAL)
What it's actually cleared for: Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery
Last verified: August 6, 2026 · How we verify
New: $150k–$200k|Used: $50k–$100kmarket estimate, no email required
Bottom line
The category leader in radiofrequency-assisted lipolysis (RFAL) and the strongest brand halo in surgical body contouring — patients ask for it by name. The real business case is the handpiece family: BodyTite for trunk/limbs, FaceTite for lower face/neck, AccuTite for tiny zones, usually bundled with Morpheus8 on the same console. Expensive new (~$150k-200k+ configured), InMode negotiates hard, and single-use electrode economics add per-case cost. If your surgeon runs cases weekly, it earns; as a trophy for an occasional-lipo practice, it won't.
Overview
Internal-external electrode contraction
How it works
The science
Bipolar RF between an internal probe (inserted under the skin alongside or after liposuction) and an external electrode gliding on the surface. Current flowing between them heats the fat compartment and fibroseptal network/dermal underside to controlled coagulation temperatures, producing fat coagulation and soft-tissue contraction plain lipo can't deliver. Onboard thermistors monitor internal and skin temps and cut energy at preset limits. Used to tighten skin during lipo of arms, abdomen, thighs, neck. Contraction claims of 30%+ come from company-affiliated studies; real-world tightening is meaningful but more modest.
Patented tech
RFAL is InMode's coined term for the internal-external bipolar electrode geometry with real-time thermal feedback; FaceTite and AccuTite are the same tech scaled down in probe size and power.
Origin
InMode Ltd., Israel.
FDA & regulatory status
What it's actually cleared for:
Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery
510(k) numbers
K171593; K182325; K240780
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
What practices charge
~$8,000-18,000 for BodyTite cases (often with lipo of 1-3 areas), $6,500-12,000 FaceTite/neck, $2,500-5,000 AccuTite zones; Morpheus8 series commonly bundled to lift the ticket.
Consumables & recurring cost
Sterile single-use internal electrodes ~$300-700 per case, account-locked to registered InMode customers — ~$15k-40k/year at real surgical volume. Handpieces are capital items that cost five figures to replace out of warranty.
Ideal for
Best-fit practice
Plastic, facial plastic, and cosmetic surgeons with regular lipo volume — unambiguously a physician-surgeon device even though InMode sells heavily into surgeon-directed medspas for the Morpheus8 side. Patients: 30s-60s with mild-to-moderate laxity avoiding excisional surgery.
Compliance
Medical director & delegation
The Tite handpieces are surgical — physician-performed under state office-surgery and liposuction regulations; only the non-invasive applicators on the console can be delegated.
Contraindications & screening
Pacemakers/ICDs and implanted metal near the field, pregnancy, bleeding disorders/anticoagulants, active infection, severe laxity better served by excision, poor healing (diabetes, smoking).
Ownership
Warranty & service
12-month standard; extended ~$10k-25k/year; InMode service is responsive but handpiece repairs are proprietary and pricey.
Resale & used market
One of the most liquid used platforms thanks to Morpheus8 demand — BodyTite Pro workstations ~$40k-80k and move fast; account-locked consumables complicate second ownership — verify transferability first.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA K-numbers
K151358; K171593; K182325 → K171593; K182325; K240780
Source: Automatic record update
August 5, 2026
FDA indication
RF-assisted lipolysis system cleared for electrocoagulation and hemostasis in surgical procedures (contouring marketed under coagulation indication) → Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery
Source: Automatic record update
August 5, 2026
FDA K-numbers
K171593; K182325; K240780 → K151358; K171593; K182325
Source: Automatic record update
August 5, 2026
FDA indication
Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery → RF-assisted lipolysis system cleared for electrocoagulation and hemostasis in surgical procedures (contouring marketed under coagulation indication)
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.